We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
(+8.9%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$127M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$126M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$122M |
| 4 |
SkinHealth Systems
SKIN
|
+$90.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$210M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$187M |
| 3 |
XYZ
Block Inc
XYZ
|
+$111M |
| 4 |
Danaher
DHR
|
+$109M |
| 5 |
Monster Beverage
MNST
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Financials | 16.56% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Boot Barn
BOOT
$4.55B
| $23.1M | 0.1% |
259,912
+128,543
| +98% | +$11.1M |
|
227
Elevance Health
ELV
$81.9B
| $22.9M | 0.1% |
61,506
-6,146
| -9% | -$2.34M |
|
228
Revolve Group
RVLV
$1.79B
| $22.9M | 0.1% |
370,963
+281,308
| +314% | +$18.3M |
|
|
CPUH
229
DELISTED
Compute Health Acquisition Corp.
CPUH
| $22.9M | 0.1% |
2,341,833
+1,840,901
| +367% | +$17.9M |
|
230
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $22.7M | 0.09% |
180,700
-296,500
| -62% | -$38.2M |
|
231
CrowdStrike
CRWD
$187B
| $22.7M | 0.09% |
+369,352
| New | +$23.8M |
|
232
M&T Bank
MTB
$36.2B
| $22.7M | 0.09% |
151,775
+128,228
| +545% | +$17.8M |
|
|
233
Monster Beverage
MNST
$91.4B
| $22.6M | 0.09% |
508,844
-2,128,944
| -81% | -$101M |
|
|
HHLA
234
DELISTED
HH&L Acquisition Co.
HHLA
| $22.5M | 0.09% |
2,311,227
+2,002,553
| +649% | +$19.4M |
|
235
American Express Global Business Travel
GBTG
$4.91B
| $22.4M | 0.09% |
2,290,524
+585,825
| +34% | +$5.71M |
|
236
Royal Caribbean
RCL
$78.7B
| $22.3M | 0.09% |
+251,075
| New | +$20.3M |
|
237
SAP
SAP
$187B
| $22.3M | 0.09% |
165,217
+70,862
| +75% | +$10.3M |
|
238
Capital One
COF
$124B
| $22.3M | 0.09% |
137,505
+38,213
| +38% | +$6.24M |
|
239
Goldman Sachs
GS
$313B
| $22.1M | 0.09% |
58,563
-25,017
| -30% | -$9.77M |
|
240
Omnicom Group
OMC
$22.7B
| $22.1M | 0.09% |
305,125
+227,280
| +292% | +$16.9M |
|
241
Crocs
CROX
$6.69B
| $21.9M | 0.09% |
152,915
-150,959
| -50% | -$20.7M |
|
242
Darling Ingredients
DAR
$9.93B
| $21.9M | 0.09% |
304,093
+114,435
| +60% | +$8.19M |
|
243
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $21.8M | 0.09% |
+198,300
| New | +$22.3M |
|
244
SS&C Technologies
SSNC
$17.8B
| $21.7M | 0.09% |
+313,285
| New | +$23.2M |
|
245
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $21.7M | 0.09% |
832,400
+367,800
| +79% | +$9.11M |
|
246
Grocery Outlet
GO
$891M
| $21.6M | 0.09% |
+1,000,690
| New | +$28.8M |
|
247
Twilio
TWLO
$29.1B
| $21.5M | 0.09% |
67,332
+65,937
| +4,727% | +$24M |
|
248
CALL
Las Vegas Sands
LVS
$30.5B
| $21.4M | 0.09% |
+585,800
| New | +$25.1M |
|
249
Avis
CAR
$5.63B
| $21.4M | 0.09% |
183,621
+47,715
| +35% | +$4.21M |
|
|
BBL
250
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $21.3M | 0.09% |
420,239
-270,759
| -39% | -$16.3M |
|
Similar funds
Marshall Wace's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.
- Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
- Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
- Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
- Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
- Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
- Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
- Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.
Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.